维普期刊资源整合服务平台（V6.5）

75篇 您的检索式：作者名="MONTEMURRO M"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts 显示文摘	Antonello M Montemurro D Bolognesi M	2007	American Journal of Hypertension2007，20，12：	1
2	Trastuzum ab:mechanism of action, resistance and Future perspectives in Her-2 overexpressing breast cancer显示文摘	Valabrega G Montemurro F Aglietta M	2007	Ann Oncol2007，18，6：	1
3	Nilotinib in the treatment of advanced gastrointes-tinal stromal tumours resistant to both imatinib and sunitinib显示文摘	Montemurro M	2009	Eur J Cancer2009，45，13：	1
4	Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma:a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase Ⅱ trial (SAKK 77/06)显示文摘	Koeberle D Montemurro M Samaras P	2010	Oncologist2010，15，3：	1
5	Prevention and treatment of febrile neutropenia 显示文摘	MONTEMURRO F GALLICCHID M AGLIETTA M	1997	Tumori1997，83，2：	1
6	Immunophenotypic heterogeneity of hyalinzing trabecular tumors of the thyroid显示文摘	Papotti M Riella P Montemurro F	1997	Histopathology1997，31，6：	1
7	Lapatinib: a dual inhibitor of EGFR and HER-2 tyrosine kinase activ- ity 显示文摘	Montemurro F Valabrega G Aglietta M	2007	Expert Opin Biol Ther2007，7，2：	1
8	Selectively enhanced cellular signaling by Gi proteins in essential hypertension: Gi2, Gi3,Gβ1, and Gβ2 are not mutated显示文摘	Pietruck F Moritz A Montemurro M	1996	Circ Res1996，79，：	1
9	Continuous sunitinib treatment in patients with unresectable hepatocellular carcinoma (HCC): A muhicenter phase 11 trial (SAKK 77/06 and SASL 23) 显示文摘	KOEBERLE D MONTEMURRO M SAMARAS P	2009	J Clin 0ncol2009，27，15：	1
10	Outcome of pa- tients with HER2-positive advanced breast cancer progressing during trastuzumab-based therapy显示文摘	Montemurro F Donadio M Clavarezza M	2006	Oncologist2006，11，4：	1
11	Trastuzumab:mechanism of action,resistance and future perspectives in HER-2-overexpressing breast cancer显示文摘	Valabrega G Montemurro F Aglietta M	2007	Ann Oncol2007，18，6：	1
12	Trastuzumab:mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer显示文摘	Valabrega G Montemurro F Aglietta M	2007	Ann Oncol2007，18，：	1
13	Trastuzum-ab: mechanism of action, resistance and future perspectives inHER2-overexpressing breast cancer 显示文摘	VALABREGA G MONTEMURRO F AGUETTA M	2007	Ann Oncol2007，18，6：	1
14	Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer显示文摘	Valabrega G Montemurro F Aglietta M	2007	Ann Oncol2007，18，6：	1
15	Blood and tissue fibrinolytic profiles in patients with colorectal carcinoma显示文摘	Montemurro P Conese M Altomare DF	1995	Int J Ciln Lab Res1995，25，4：	1
16	Early prediction of response to sunitinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor 显示文摘	Prior JO Montemurro M Orcurto MV	2009	J Clin Oncol2009，27，：	1
17	Selected highlights from the 26th San Antonio Breast Cancer Symposium显示文摘	Montemurro F Aglietta M	2004	Expert Opinion on Pharmacothery2004，5，4：	1
18	Long term effects of or- ganic amend ments on soil fertility:A review 显示文摘	DIACONO M MONTEMURRO F	2010	Agronomy for Sustainable Development2010，30，2：	1
19	Continuous sunitinib in patients with unresectable hepatocellular caicinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver(SASL) multicenter phase II trial ( SAKK 77/06 ) 显示文摘	KOEBERLE D MONTEMURRO M SAMARAS P	2010	Oncologist2010，15，3：	1
20	Trastuzumab-based combination therapy for breast-cancer显示文摘	Montemurro F Valabrega G Aglietta M	2004	Expert Opin Pharmatother2004，5，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示